BioPharma Credit (LON:BPCR) Insider Buys £69,300 in Stock

BioPharma Credit (LON:BPCR – Get Free Report) insider Graeme Proudfoot bought 70,000 shares of the stock in a transaction dated Tuesday, September 29th. The stock was bought at an average cost of GBX 99 per share, with a total value of £69,300.

BioPharma Credit Price Performance

Shares of BPCR stock opened at GBX 0.98 on Friday. The stock has a market capitalization of £11.00 million, a PE ratio of 0.09 and a beta of 0.23. BioPharma Credit has a 1-year low of GBX 0.88 and a 1-year high of GBX 1. The business has a 50-day moving average of GBX 0.97 and a 200 day moving average of GBX 0.96.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.